A detailed history of Oppenheimer Asset Management Inc. transactions in Insmed Inc stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 21,374 shares of INSM stock, worth $3.45 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
21,374
Previous 19,935 7.22%
Holding current value
$3.45 Million
Previous $1.52 Million 41.51%
% of portfolio
0.03%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

BUY
$64.81 - $105.9 $93,261 - $152,390
1,439 Added 7.22%
21,374 $2.15 Million
Q1 2025

Apr 22, 2025

BUY
$65.25 - $83.83 $355,808 - $457,124
5,453 Added 37.65%
19,935 $1.52 Million
Q4 2024

Feb 04, 2025

BUY
$66.29 - $76.63 $2,187 - $2,528
33 Added 0.23%
14,482 $999,000
Q3 2024

Nov 05, 2024

BUY
$62.0 - $79.01 $480,562 - $612,406
7,751 Added 115.72%
14,449 $1.05 Million
Q2 2024

Aug 08, 2024

BUY
$22.0 - $69.71 $147,356 - $466,917
6,698 New
6,698 $448,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $21.9B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.